NCT06273280View on ClinicalTrials.gov

Renal-based Optimization of QUADruple Therapy in Patients With Heart Failure With Reduced Ejection Fraction.

NAActive, not recruitingINTERVENTIONAL

Enrollment

345

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions

Heart FailureHeart Failure With Reduced Ejection Fraction

Interventions

PROCEDURE

SOC

Physician-guided GDMT up-titration

PROCEDURE

Protocolized up-titration

Renal-based protocolized GDMT up-titration

Trial Locations (1)

3600

Ziekenhuis Oost-Limburg AV, Genk

All Listed Sponsors

collaborator

King Baudouin Foundation

OTHER

lead

Ziekenhuis Oost-Limburg

OTHER

NCT06273280 - Renal-based Optimization of QUADruple Therapy in Patients With Heart Failure With Reduced Ejection Fraction. | Biotech Hunter | Biotech Hunter